From startups to leading global companies, Greater Fort Lauderdale provides a stimulating and supportive business environment for success in the life sciences.

An aging population, an ever increasing amount of time viewing digital devices and a growing trend in eye diseases are all factors expected to fuel a global…

Sarepta Therapeutics

Sarepta jumps on J.P. Morgan update, gene therapy DMD deals

An easy pass for Cures; so too for new meds?

FDA's new drugs director Jenkins retires, months after criticizing regulator, RAPS reports

Law firm that believes FDA is ‘broken’ highlights Cures Act fears

Sarepta bemoaned ‘dire’ financial situation as it pushed for Exondys decision

Hedge fund Perceptive raises $323M life sciences debt fund

FDA expert lashes out at 'worrisome' Sarepta approval in JAMA

Summit, Sarepta in $584M-plus DMD pipeline license pact in Europe

Sarepta CEO Ed Kaye on FDA courage, NICE and resilience

Sarepta not sure of patient numbers--but is sure of $300K-plus price tag